Wells Fargo is raising its valuation range on shares of Charles River Laboratories CRL to $44-$45 from $42-$43.
Charles River Laboratories currently trades at $37.73.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Posted In: Analyst RatingsCharles River LaboratoriesHealth CareLife Sciences Tools & ServicesWells Fargo
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
